Sigilon Therapeutics

Immune-privileged living therapeutics

Type

B2c

Raised

$80.3M

Follow us

Also headquartered in Cambridge

Companies in the same industry

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Latest funding

$80,300,000

Venture capital (Series B) - 2020

Eli Lilly and Company Flagship Pioneering Canada Pension Plan Investment Board (CPP Investments) +1

Undisclosed amount

Undisclosed funding - 2018

Team Size

1–10

Employees

Location

Headquarters

$80,300,000 Venture capital (Series B)

Undisclosed funding